OB/GYN News

View more issues:

Articles in March 15, 2005 issue of OB/GYN News

• Patient concerns drive wart treatment
  by Jane Salodof MacNeil
• What to do if breast MRI isn't a screening option
  by Bruce Jancin
• Amnioinfusion trial fails to prevent meconium aspiration
  by Timothy F. Kirn
• Adding exercise to your routine
  by Doug Brunk
• FDA issues class 1 recall on urine processing kit, citing false outcomes
  by Kerri Wachter
• New ACIP flu vaccine guidelines focus on prioritization, health care workers
  by Miriam E. Tucker
• CDC study: most new cases of HIV, AIDS in women occur in blacks
  by Sharon Worcester
• Flu vaccine safe in second half of pregnancy
  by Robert Finn
• Preeclampsia presentation varies depending on race and ethnicity
  by Robert Finn
• 17P: best for prior preterm births before 34 weeks
  by Robert Finn
• An agenda of ignorance
  by Kenneth R. Weinberg
• Embryo selection no longer a 'beauty contest'
  by Betsy Bates
• Score on cardiovascular profile predicts survival in fetuses with heart failure
  by Robert Finn
• Natural supplements help lower blood lipids
  by Doug Brunk
• Physicians: medicare formula is priority in reform
  by Jennifer Silverman
• Increasing HIV screening
  by Mary Ellen Schneider
• Patients influenced by drugs' brand power
  by Carl Sherman
• Patient-delivered Tx for partners reduces gonorrhea, chlamydia rates
  by Kate Johnson
• The chasm between physicians, lawyers
  by James S. Bostwick
• Warts do not always indicate recent infection: only 20% of new human papillomavirus infections actually produce lesions during the first few months
  by Jane Salodof MacNeil
• Incidence of RDS greater in preterm ART twins
  by Timothy F. Kirn
• How to advise patients seeking CAM therapy
  by Doug Brunk
• President's budget plan takes first step with IT network
• Legislating sex education
  by Mary Ellen Schneider
• Sen. Breaux pushes for individual insurance mandate
  by Mary Ellen Schneider
• Maternal morbidity rises sharply with repeat cesareans: largest increase seen after fourth delivery
  by Robert Finn
• Weighing the risks of COX-2 inhibitors
  by Arnold Kim
• Survey: tests of embryos OK for health purposes
  by Kate Johnson
• Neonatal withdrawal syndrome and SSRIs
  by Lee Cohen
• Four diets modestly curb cardiac risk factors; compliance an issue
  by Kevin Foley
• Investigating cesarean rates
  by Mary Ellen Schneider
• More data needed for consumer-driven health care
  by Joyce Frieden
• Periodontal disease raises preterm risk
  by Betsy Bates
• Developmental abnormalities easy to misdiagnose
  by Jane Salodof MacNeil
• Prenatal exposure to pollution may result in chromosomal damage
  by Christine Kilgore
• Focus on the 'other' lice
  by Diana Mahoney
• Electronic prescribing is gaining momentum
  by Mary Ellen Schneider
• Perceptions of the drug industry
  by Mary Ellen Schneider
• New HIV therapies challenge gynecologic care: with more than 30 treatment options, obstetricians' knowledge of HIV drugs should go beyond AZT
  by Jane Salodof MacNeil
• Prophylactic mastectomy lowers risk of breast cancer 90%
  by Bruce Jancin
• Pregnancy-induced hypertension tied to metabolic syndrome
  by Sharon Worcester
• Win a portable DVD player!
• Seropositive rate doubles with rapid HIV-1 antibody test
  by Heidi Splete
• X-rays, gamma rays added to carcinogen list
  by Kerri Wachter
• Nuchal translucency predicts fetal heart disease: when screening is added to first-trimester exam, it can pick up defects that otherwise would have been missed
  by Timothy F. Kirn
• Hysteroscopy
  by Bruce L. Flamm
• Medical care spending outstrips inflation
• Early West Nile case may bode ill for western U.S
  by Betsy Bates
• Study gives UAE mixed results on morbidity
  by Deeanna Franklin
• Complications in pregnant 10- to 14-year-olds
• Questions linger about use of COX-2 inhibitors: an FDA advisory panel says evidence supports the continued marketing of selective COX-2 inhibitors
  by Elizabeth Mechcatie
• Alcohol use during pregnancy
  by Mary Ellen Schneider
• Controversy continues over prayer, IVF study
  by Joyce Frieden